The Strongest Predictor of How Long You'll Live
There is a single measurement that predicts how long you will live more reliably than your cholesterol panel, your blood pressure, your weight, whether you smoke, or whether you have diabetes. It is called cardiorespiratory fitness, and most people have never had it measured.
In 2018, researchers at the Cleveland Clinic published a study that followed 122,000 patients over a decade and measured their cardiorespiratory fitness using treadmill exercise testing. The findings were stark. Patients in the lowest fitness quintile were five times more likely to die during the study period than those in the highest. More strikingly, the effect of low fitness on mortality was larger than the effect of smoking, hypertension, diabetes, or end-stage kidney disease. When the researchers compared the extremes, the mortality risk associated with the lowest fitness category was 500 percent higher than the highest, while smoking added roughly 40 percent risk.
The number that summarises cardiorespiratory fitness is called VO2max. The evidence that it predicts your lifespan is now as robust as anything in preventive medicine.
This article explains what VO2max is, why it declines, and why that matters for the rest of your life. It makes the case for why intensity specifically matters, not just total exercise volume. It covers the second lever, muscle strength, which is an independent predictor of mortality that most people undervalue. And it closes with what to actually do.
What VO2max is, and the number you need to be
VO2max is the maximum rate at which your body can take in and use oxygen during intense exercise. It is expressed in millilitres of oxygen per kilogram of body weight per minute, which makes it comparable across people of different sizes. The number captures the integrated function of your heart, lungs, blood, and muscles: how efficiently they work together under load. A sedentary middle-aged adult might sit around 30 to 35 ml/kg/min. A reasonably fit person in their forties might be 40 to 45. An elite endurance athlete might be above 70.
The uncomfortable arithmetic is this: without deliberate training, VO2max declines roughly ten percent per decade after the age of thirty. By seventy, a sedentary person may have lost forty percent or more of the capacity they had at thirty. This is not just a number on a test. It is the machinery behind every demanding physical task, and when it falls far enough, ordinary life starts to feel hard.
The most useful way to think about your VO2max is not where it sits today but where you will need it to be in twenty or thirty years. Because the decline is predictable, you can work backwards: to be able to do something comfortably at seventy-five, you need a higher number today.
The activities you want to still do, and what they cost
Physiologists measure activity intensity in METs, metabolic equivalents, where one MET equals the energy cost of sitting quietly. Every physical activity has a MET value, and VO2max determines how much of your maximum capacity each activity consumes. Sustained activities are typically performed at around seventy to eighty percent of VO2max: anything requiring more than that for longer than a minute or two is not sustainable for long.
The table below translates common activities at age seventy-five into the VO2max required to do them comfortably, and then into the number a fifty-year-old would need today, assuming a passive decline of roughly twenty-five percent between fifty and seventy-five with no training.
| Activity at age 75 | VO2max needed at 75 | Needed at 50 to coast there |
|---|---|---|
| Carry groceries up one flight of stairs | ~18 ml/kg/min | ~24 |
| Climb three flights without stopping | ~22 ml/kg/min | ~29 |
| Brisk thirty-minute walk | ~24 ml/kg/min | ~32 |
| Full day of moderate hiking | ~30 ml/kg/min | ~40 |
| Run a slow 5km | ~33 ml/kg/min | ~44 |
| Run a 10km | ~40 ml/kg/min | ~53 |
At 45, a VO2max of 38 places you in the above average — 50th–75th percentile for your age group. Projecting to 80: the sedentary path lands at 26, the trained path at 33 — a 7-point gap. The sedentary path preserves basic independence at 80, but running is gone. Training preserves it.
The numbers are approximate, but the principle is exact. If you are fifty and your VO2max is 28, you are coasting toward a seventy-five-year-old who struggles on stairs. If you are fifty and your VO2max is 45, you are coasting toward a seventy-five-year-old who can still run. The gap between those two lives is almost entirely determined by what you do in the intervening decades, because VO2max is one of the most trainable physiological parameters there is.
Where you stand
The table below gives approximate age-matched percentiles drawn from large population studies. These are the numbers that matter for interpreting your own fitness.
Men (ml/kg/min)
| Age | Low (<25th) | Average (25–75th) | Above average (75–90th) | High (>90th) |
|---|---|---|---|---|
| 30–39 | <34 | 34–48 | 48–55 | >55 |
| 40–49 | <30 | 30–44 | 44–53 | >53 |
| 50–59 | <25 | 25–39 | 39–48 | >48 |
| 60–69 | <21 | 21–35 | 35–45 | >45 |
Women (ml/kg/min)
| Age | Low (<25th) | Average (25–75th) | Above average (75–90th) | High (>90th) |
|---|---|---|---|---|
| 30–39 | <27 | 27–41 | 41–47 | >47 |
| 40–49 | <24 | 24–38 | 38–44 | >44 |
| 50–59 | <20 | 20–34 | 34–41 | >41 |
| 60–69 | <18 | 18–30 | 30–37 | >37 |
The most striking thing about these tables, read alongside the mortality data, is how much protection sits in the move from low to average. That single transition was associated with a roughly fifty percent reduction in mortality risk in the Mandsager study. Moving from average to high produces further gains, with a roughly linear dose-response continuing into the elite range.
The cardiovascular evidence
The mechanisms through which cardiorespiratory fitness protects the heart are well understood and operate independently of weight loss. Regular vigorous exercise lowers resting blood pressure, improves endothelial function (the health of the blood vessel lining, whose role in atherosclerosis is covered in the cholesterol article), reduces resting heart rate, increases HDL, lowers triglycerides, and reduces systemic inflammation. These changes occur even when body weight does not change, which matters because it means cardiovascular training is not merely a weight-loss intervention in exercise clothing.
The dose-response relationship between exercise and cardiovascular risk is not a simple straight line. Two inflection points are visible in the data. The first is the transition from sedentary to any regular movement: the mortality reduction here is large and rapid, because the baseline risk of complete inactivity is so high that even modest exercise produces substantial returns. The second inflection appears at the vigorous intensity threshold, where a disproportionate additional reduction in cardiovascular mortality is visible that cannot be fully explained by the extra volume alone.
The clearest evidence for this second inflection comes from the HUNT study, a large Norwegian cohort that has followed tens of thousands of people across decades. Vigorous exercise reduced cardiovascular mortality beyond what moderate exercise achieved, even after the researchers statistically equalized total exercise volume. Two people doing the same weekly exercise minutes, one at moderate intensity and one at vigorous, ended up with meaningfully different cardiovascular outcomes. The implication is important: intensity is not just a faster way to accumulate minutes. It is doing something that moderate exercise does not fully replicate.
A question that sometimes comes up is whether vigorous exercise is safe. Vigorous exercise does produce a transient, acute elevation in cardiac risk during the session itself, particularly in people who are unfit and exercise rarely. But the chronic protective effect over a lifetime of training is so large that regular vigorous exercisers have dramatically lower cardiovascular mortality than sedentary people. The risk concern has the arithmetic backwards. The danger is not vigorous exercise. The danger is not doing it.
Beyond the heart: the full mortality picture
Cardiorespiratory fitness does not only protect the cardiovascular system. The mortality benefits extend across almost every major cause of death, and the evidence base has grown substantially in the last decade.
Cancer. In 2016, researchers pooled data from twelve prospective cohorts covering 1.44 million people and found that higher leisure-time physical activity was associated with lower risk of thirteen of the twenty-six cancer types studied, including colon, breast, endometrial, liver, kidney, and lung cancer. The mechanisms include reduced systemic inflammation, improved insulin sensitivity, lower circulating oestrogen and insulin-like growth factor 1, and direct effects on immune function. This is not one mechanism working on one cancer. It is a broad suppression of the biological conditions that allow cancer to establish itself.
Metabolic disease. Vigorous exercise improves insulin sensitivity through multiple pathways, including GLUT4 translocation in muscle cells, AMPK activation (covered in the mTOR and AMPK article), and increased glucose uptake in trained muscle. The risk reduction for type 2 diabetes in regularly active people compared to sedentary people is roughly 30 to 50 percent in large prospective studies.
Cognitive decline. Vigorous aerobic exercise is the most reliably effective intervention for preserving cognitive function with age. The mechanism centres on BDNF, brain-derived neurotrophic factor, a protein that promotes the growth and maintenance of neurons and is strongly stimulated by vigorous exercise. The clinical data show that regular exercisers have larger hippocampal volume, better memory performance, and reduced dementia risk. A 2020 Lancet Commission report identified physical inactivity as one of twelve modifiable risk factors for dementia, accounting for an estimated two percent of cases globally.
All-cause mortality. The headline number: people in the top fitness quintile had roughly five times lower all-cause mortality than those in the bottom. For comparison, statin therapy reduces cardiovascular mortality by about 25 to 35 percent in high-risk patients. The effect size of fitness on total mortality is substantially larger than the effect of most medications on any single disease. Exercise is not a lifestyle choice in the same category as taking a supplement. It is the highest-leverage health intervention available to most people, and the evidence base is larger and more consistent than for almost any drug.
Why intensity specifically matters
Most public health guidance focuses on duration. The standard recommendation in most countries is 150 minutes per week of moderate-intensity activity, a target based on solid evidence and genuinely useful. But intensity is an independent variable with its own outsized returns, and the “150 minutes at moderate pace” framing can obscure this.
The adaptations that specifically require vigorous intensity are meaningfully different from those produced by moderate exercise.
VO2max gains. Moderate exercise does improve VO2max modestly. Vigorous exercise improves it substantially. A meta-analysis comparing high-intensity interval training to moderate-intensity continuous training at matched volumes found that high-intensity protocols produced significantly greater VO2max improvements. You cannot fully substitute more time for more intensity when the goal is cardiorespiratory fitness improvement. The heart and lungs adapt most strongly to demands placed at or near their limits.
Cardiac remodeling. Sustained vigorous exercise over months and years produces structural changes to the heart, specifically an increase in the size and wall thickness of the left ventricle. This is what is sometimes called “athlete’s heart,” and it represents a genuine mechanical advantage: a larger ventricle pumps more blood per beat, which lowers resting heart rate and improves the heart’s ability to respond to sudden demands. Moderate exercise produces some of this adaptation; vigorous exercise drives it more completely.
BDNF and neurological protection. The intensity threshold for meaningful BDNF elevation appears to sit in the vigorous range. Studies comparing different exercise intensities on BDNF response consistently show that higher intensities produce larger acute elevations. Given the role of BDNF in neuroplasticity, cognitive reserve, and mood regulation, the neurological case for vigorous exercise is distinct from and complementary to the cardiovascular one.
What does vigorous intensity actually mean in practice? Roughly 77 to 95 percent of maximum heart rate. Breathing hard enough that conversation is difficult but not impossible. A level of effort that feels genuinely demanding but that you can sustain for minutes at a time, not just seconds. This is not a mystical zone accessible only to athletes. It is a specific physiological range that most healthy adults can reach.
The goal is not to replace moderate exercise with vigorous. Zone 2 cardio, the conversational aerobic pace, does something different and valuable: it builds aerobic base, trains fat oxidation, and is sustainable in high volumes without excessive recovery cost. The two types of training are complementary. A well-structured training week uses both. The common mistake is omitting the vigorous sessions entirely, which is what most people do.
The second lever: muscle strength
VO2max is not the complete picture. Muscle strength is an independent predictor of all-cause mortality, meaning the protection it provides sits on top of, not explained by, cardiorespiratory fitness. Neglecting either lever leaves significant risk on the table.
The clearest evidence comes from the PURE study, published in The Lancet in 2015. Researchers measured grip strength in 139,691 adults across seventeen countries and followed them for approximately four years. Grip strength predicted all-cause mortality, cardiovascular mortality, and cardiovascular events better than systolic blood pressure. Every five-kilogram decrease in grip strength was associated with a 16 percent higher risk of all-cause mortality. This held across all countries and income levels in the study.
Grip strength matters not because a strong grip is itself protective, but because it is a reliable proxy for overall muscular strength and lean muscle mass. Low grip strength flags sarcopenia risk and downstream functional decline.
The mechanisms by which muscle strength protects health are distinct from the cardiorespiratory ones. Muscle tissue is metabolically active, acting as the largest glucose sink in the body and playing a central role in insulin sensitivity. Trained muscle produces myokines, signalling molecules released during contraction that have anti-inflammatory, neuroprotective, and metabolic effects throughout the body. These are part of the reason exercise has such broad systemic benefits: muscle does not just move you, it signals to every other organ. Resistance training also preserves bone mineral density, an effect that becomes increasingly important in the sixth decade and beyond, and reduces the risk of the falls and injuries that disproportionately affect people with low muscle mass.
The practical implication is straightforward. A complete longevity training programme requires both a cardiorespiratory component and a strength component. A person who runs marathons but does no resistance training, and a person who lifts heavy but never raises their heart rate significantly, are each protecting one lever while leaving the other exposed.
What to monitor
Four markers have mortality-linked evidence and are practical to track. None of these are vanity metrics: each one captures something the research specifically connects to health outcomes.
VO2max. The primary number. Consumer wearables give estimates from heart rate data during exercise and are useful for tracking trends. A graded exercise test at a sports medicine or cardiology facility gives the real figure. It is worth getting at least one proper test to calibrate your wearable estimate. Once you have it, the age-matched percentile table above is more useful than the raw number. The goal is moving up the percentile distribution for your age and, over time, slowing the age-related decline.
Grip strength. Measured with a hand dynamometer, inexpensive and widely available. Normative reference ranges by age and sex exist from the PURE study and other large cohorts. A measurement takes thirty seconds and gives you a baseline worth tracking annually.
Resting heart rate. A long-term proxy for cardiorespiratory fitness. As aerobic fitness improves, the heart becomes more efficient and resting rate drops. A downward trend over months of training is a reliable signal that adaptation is occurring. Most wearables measure this passively during sleep.
HRV. Heart rate variability reflects the autonomic nervous system and correlates with fitness level and recovery state. Its primary value is as a personal baseline trend: a chronic upward trend over months signals improving fitness and recovery capacity. The wearables article covers HRV in detail.
What not to over-monitor: body weight alone, daily step count as a primary fitness metric, or single-session performance numbers. These provide information but none of them is directly connected to the mortality outcomes described in this article.
The prescription
For the currently sedentary: start
The priority for someone who does nothing at present is to start, not to optimise. Even fifteen minutes of brisk walking daily produces measurable mortality reduction. The goal for the first two to three weeks is to establish a movement habit at any intensity. Every study showing mortality benefits from exercise includes people who started from zero.
The evidence-based weekly structure
Once basic movement is established, a week that delivers the documented benefits looks like this.
Zone 2 cardio, two to three sessions. Conversational pace, thirty to forty-five minutes each. This builds aerobic base, increases mitochondrial density in muscle cells, and trains fat oxidation. It should feel sustainable: the point is volume, not intensity.
Vigorous interval work, one to two sessions. Effort at roughly 80 to 95 percent of maximum heart rate, in intervals of two to eight minutes with recovery periods. Twenty to thirty minutes total including warmup. This is where the majority of VO2max gains occur. Specific protocols vary, but all share the same requirement: genuinely high effort. One well-executed vigorous session per week produces meaningful adaptation. Two is better for those who can recover from them.
Resistance training, two sessions. Full-body or upper/lower split. Compound movements: exercises that work multiple joints simultaneously, squats, deadlifts, pressing, pulling, rows. Progressive overload over time, meaning the training demand should gradually increase rather than staying constant. Thirty to sixty minutes per session is sufficient. The specifics of programming are covered in the dedicated resistance training article.
One day of full rest or active recovery. Mobility work, a slow walk, or nothing. Adaptation from training happens during recovery, not during the session. Skipping recovery does not improve results; it degrades them.
Age-specific notes
Under forty, higher intensity volume is generally well tolerated and progression is faster. The structure above applies with fewer constraints.
In the forties and fifties, injury risk management becomes as important as training load. Technique matters more than it did at thirty; a movement flaw that was harmless at twenty-five can become a source of chronic pain at fifty. Recovery between sessions takes longer. None of this is a reason to train less. It is a reason to train more carefully: controlled tempo, adequate warm-up, and willingness to back off load when something feels wrong. The return on training at this age, in terms of preventing future decline, is very high.
At sixty and beyond, resistance training moves from beneficial to essential. The rate at which muscle mass accelerates its decline in the seventh decade makes strength training the primary defence against loss of functional independence. Cardiorespiratory training remains valuable but session structure may need adjustment. The full picture for older adults, including what can realistically be reversed and the specific strength standards worth targeting, is covered in the dedicated article on sarcopenia and ageing.
A note on coaching: working with a qualified trainer for the first few months, someone who can actually watch you move and correct technique in real time, is the highest-leverage investment most beginners can make. Online programming and apps work well once the foundation is in place. Getting the foundation right from the start removes the injury risk that is the single most common reason people stop training.
The short version
Cardiorespiratory fitness, measured by VO2max, is the strongest single predictor of all-cause mortality, outperforming smoking, blood pressure, diabetes, and most other modifiable risk factors. The protection extends well beyond the heart to cancer, metabolic disease, cognitive decline, and overall longevity, with people in the top fitness quintile showing roughly five times lower all-cause mortality than those in the bottom.
Intensity matters independently. Vigorous exercise, at roughly 77 to 95 percent of maximum heart rate, produces adaptations that moderate exercise does not fully replicate: VO2max gains, cardiac remodeling, and neurological protection via BDNF. The goal is not to replace moderate exercise with vigorous but to add vigorous sessions to a structure that also includes aerobic base work.
Muscle strength, proxied by grip strength, is a second independent predictor. The PURE study found it predicted cardiovascular and all-cause mortality better than blood pressure. The mechanisms are distinct from the cardiorespiratory ones and require resistance training specifically.
A week that covers the evidence looks like two to three Zone 2 sessions, one to two vigorous interval sessions, and two resistance sessions. The exact structure matters less than the consistency. The best training programme is the one still running in ten years.
References
- Mandsager, K., Harb, S., Cremer, P., Phelan, D., Nissen, S.E., & Jaber, W. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 1(6), e183605. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
- Nes, B.M., Vatten, L.J., Nauman, J., Janszky, I., & Wisløff, U. (2015). A Simple Nonexercise Model of Cardiorespiratory Fitness Predicts Long-Term Mortality. Medicine & Science in Sports & Exercise, 47(6), 1253–1260. https://pubmed.ncbi.nlm.nih.gov/25251047/
- Moore, S.C., Lee, I.M., Weiderpass, E., et al. (2016). Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults. JAMA Internal Medicine, 176(6), 816–825. https://pubmed.ncbi.nlm.nih.gov/27183032/
- Leong, D.P., Teo, K.K., Rangarajan, S., et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. The Lancet, 386(9990), 266–273. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62000-6/fulltext
- Milanović, Z., Sporiš, G., & Weston, M. (2015). Effectiveness of High-Intensity Interval Training (HIIT) and Continuous Endurance Training for VO2max Improvements: A Systematic Review and Meta-Analysis of Controlled Trials. Sports Medicine, 45(10), 1469–1481. https://pubmed.ncbi.nlm.nih.gov/26243014/
- Ekelund, U., Steene-Johannessen, J., Brown, W.J., et al. (2016). Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? The Lancet, 388(10051), 1302–1310. https://pubmed.ncbi.nlm.nih.gov/27475271/
- Lee, D.C., Pate, R.R., Lavie, C.J., Sui, X., Church, T.S., & Blair, S.N. (2014). Leisure-Time Running Reduces All-Cause and Cardiovascular Mortality Risk. Journal of the American College of Cardiology, 64(5), 472–481. https://pubmed.ncbi.nlm.nih.gov/25082581/
- Livingston, G., Huntley, J., Sommerlad, A., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413–446. https://pubmed.ncbi.nlm.nih.gov/32738937/
- Wisløff, U., Støylen, A., Loennechen, J.P., et al. (2007). Superior Cardiovascular Effect of Aerobic Interval Training Versus Moderate Continuous Training in Heart Failure Patients. Circulation, 115(24), 3086–3094. https://pubmed.ncbi.nlm.nih.gov/17548726/